Treatment of rubeosis iridis with photodynamic therapy with verteporfin - A new therapeutic and prophylactic option for patients with the risk of neovascular glaucoma?

Ophthalmic Research

Volumn 35, Issue 1, 2003, Pages 60-64

  Müller, Valeska A ^a,b   Ruokonen, Peter ^a   Schellenbeck, Meike ^a   Hartmann, Christian ^a   Tetz, Manfred ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Anterior segment neovasculature; Photodynamic therapy; Rubeosis iridis

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTRAOCULAR PRESSURE; IRIS; IRIS RUBEOSIS; NEOVASCULAR GLAUCOMA; PHOTODYNAMIC THERAPY; PILOT STUDY; PRIORITY JOURNAL; SAFETY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

GLAUCOMA, NEOVASCULAR; HUMANS; IRIS; NEOVASCULARIZATION, PATHOLOGIC; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; PORPHYRINS; RISK FACTORS;

EID: 0037256131     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068195     Document Type: Article

References (22)

1. Anderson DM, Morin DJ, Hunter WS: Rubeosis Iridis. Can J Ophthalmol 1971;6:183-188.
2. Baggesen LH: Fluorescence angiography of the iris in diabetics and non-diabetics. Acta Ophthalmol 1969;47:449-460.
3. Browning DJ, Scott AQ, Peterson CB, Warnock J, Zhang Z: The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. Ophthalmology 1998;105:776-784.
4. Brown GC, Magargal LE, Schachat A, Shah H: Neovascular glaucoma: Etiologic considerations. Ophthalmology 1984;91:315-320.
5. Gartner S, Henkind P: Neovascularization of the iris. Surv Ophthalmol 1978;22:291-312.
6. Hayreh SS, Rojas P, Podhajsky P, Montague P, Woolson RF: Ocular neovascularization with retinal vascular occlusion. Part III. Ophthalmology 1983;90:488-506.
7. Fernandez-Vigo J, Castro J, Macarro A: Diabetic iris neovascularization: Natural history and treatment. Acta Ophthalmol Scand 1997;75:89-93.
8. Ohrt V: Rubeosis iridis diabetica. Acta Ophthalmol 1958;36:556-558.
9. Orth V: Glaucoma due to rubeosis iridis diabetica. Acta Ophthalmol 1961;142:356-364.
10. Nguyen QH, Hamed LM, Sherwood MB, Roseman RL: Neovascular glaucoma after carotid endarterectomy. Ann Ophthalmol 1997;29:19-22.
11. Little HL, Rosenthal AR, Dellaporta A, Jacobson DR: The effect of panretinal photocoagulation on rubeosis iridis. Am J Ophthalmol 1976;81:804-809.
12. Wand M, Duecker DK, Aiello LM, Grant WM: Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma. Am J Ophthalmol 1978;86:332-339.
13. Schmidt-Erfurth U: Photodynamische Therapie - minimal invasive Behandlung choroidaler Neovaskularisationen. Ophthalmologe 1998;95:725-731.
14. Haimovici R, Kramer M, Miller JW, Hasan T, Flotte TJ, Schomacker KT, Gradougas ES: Localization of lipoprotein-delivered benzoporphyrin derivate in the rabbit eye. Curr Eye Res 1997;16:83-90.
15. Husain D, Miller JW, Kenney AG, Michaud N, Flotte TJ, Gradougas ES: Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. Ophthalmology 1997;104:1242-1250.
16. Miller JW, Stinson WG, Gregory WA, El-Koumy HA, Puliafito CA: Phthalocyanine photodynamic therapy of experimental iris neovascularisation. Ophthalmology 1991;98:1711-1719.
17. 3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice. J Photochem Photobiol 1990;5:231-244.
18. Ehrenberg M, McCuen BW II, Schindler RH, Machemer R: Rubeosis iridis: Preoperative iris fluorescein angiography and periocular steroids. Ophthalmology 1984;91:321-325.
19. Lindblom B: Fluorescein angiography of the iris in the management of eyes with central retinal vein occlusion. Acta Ophthalmol Scand 1998;76:188-191.
20. Küchle M, Nguyen NX, Naumann GOH: Tyndallometrie mit dem Laser-flare-cell-meter bei intraokularen Entzündungen. Ophthalmologe 1994;91:219-223.
21. Lee P-F: Goniophotocoagulation in the management of rubeosis iridis. Lasers Surg Med 1981;1:215-220.
22. Packer JA, Tse DT, Gu X-Q, Hayreh SS: Hematoporphyrin photoradiation therapy for iris neovascularization. Arch Ophthalmol 1984;102:1193-1197.